Trial site
Neuro-Behavioral Clinical Research
- 9running trials
- 7closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Schizophrenia4 trials
- Bipolar disorder3 trials
- Depression3 trials
- Sickle cell disease3 trials
- Alzheimer disease2 trials
- Thalassaemia1 trial
- Phase
- Phase 39 trials
- Phase 25 trials
- Phase 12 trials
- Status
- Recruiting6 trials
- Completed5 trials
- Active, not recruiting3 trials
- Terminated2 trials
- Lead sponsor
- Bristol-Myers Squibb3 trials
- Boehringer Ingelheim2 trials
- Cassava Sciences, Inc.2 trials
- LB Pharmaceuticals Inc.2 trials
- ACADIA Pharmaceuticals Inc.1 trial
- and 6 more
Running trials
Recruiting
Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
Recruiting
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
Recruiting
Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
Active, not recruiting
A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bipolar disorder3 recruiting
- Depression1 recruiting
- Schizophrenia1 recruiting
Closed trials
Terminated
Single-dose Pharmacokinetics of Pociredir in Participants With Sickle Cell Disease
Completed
A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
Completed
Terminated
Open-label Extension for Phase 3 Clinical Trials of Simufilam
Completed
Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-1)
Completed
Completed
Simufilam (PTI-125), 100 mg, for Mild-to-moderate Alzheimer's Disease Patients
Site data: ClinicalTrials.govUpdated 15 Nov 2026